Related Experiment Video

Updated: Jun 23, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

Pathogenesis of rheumatoid arthritis and c-Fos/AP-1

Shunichi Shiozawa1, Ken Tsumiyama

  • 1Division of Rheumatology, Department of Medicine, Kobe University Graduate School of Medicine, and The Center for Rheumatic Diseases, Kobe University Hospital, Chuoku, Kobe, Japan. shioz@med.kobe-u.ac.jp

Cell Cycle (Georgetown, Tex.)
|April 28, 2009
PubMed

Insights

Blocking IL-1beta and c-Fos/AP-1 offers a promising new therapy for rheumatoid arthritis joint destruction. This approach targets key pathways involved in cartilage and bone degradation, complementing existing treatments.

Area of Science:

  • Rheumatology
  • Molecular Biology
  • Immunology

Background:

  • Rheumatoid arthritis (RA) involves inflammation and degradation of cartilage and bone.
  • Matrix metalloproteinases (MMPs) are key enzymes responsible for tissue breakdown in RA.
  • The transcription factor c-Fos/AP-1 and inflammatory cytokine IL-1beta play critical roles in RA pathogenesis.

Purpose of the Study:

  • To investigate the role of c-Fos/AP-1 and IL-1beta in the molecular mechanisms of arthritic joint destruction.
  • To explore the therapeutic potential of targeting IL-1beta and/or c-Fos/AP-1 in rheumatoid arthritis.

Main Methods:

  • Analysis of the regulatory role of c-Fos/AP-1 on inflammatory cytokines and MMPs.
  • Investigation of the cross-talk between IL-1beta and c-Fos/AP-1 signaling pathways.
  • Evaluation of the impact of TNFalpha in conjunction with IL-1beta and c-Fos/AP-1.

Main Results:

  • c-Fos/AP-1 directly controls the expression of inflammatory cytokines and MMPs through AP-1 binding motifs.
  • IL-1beta is a primary inducer of MMPs and contributes significantly to cartilage breakdown and osteoclastogenesis.
  • IL-1beta and c-Fos/AP-1 exhibit reciprocal regulation, forming a crucial crosstalk in arthritic joint destruction, potentiated by TNFalpha.

Conclusions:

  • Selective inhibition of c-Fos/AP-1 can effectively resolve arthritic joint destruction.
  • Blocking IL-1beta and/or c-Fos/AP-1 represents a promising therapeutic strategy for rheumatoid arthritis.
  • These targets offer potential as adjunct therapies to current TNFalpha blockers for RA treatment.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.